erucin has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakare, A; Bertele, D; Drognitz, O; Erlacher, M; Giesemann, T; Hertrampf, A; Herz, C; Huber, R; Lamy, E; Lauer, U; Mersch-Sundermann, V; Rohn, S; Schüler, J; Wagner, M; Weiland, T | 1 |
| Erlacher, M; Hertrampf, A; Herz, C; Kleinhans, C; Lamy, E; Mersch-Sundermann, V; Platz, S; Rohn, S; Schüler, J; Stetter, N; Wagner, M; Zimmermann, S | 1 |
| Brenk, P; Lamy, E; Mersch-Sundermann, V; Paulus, S; Schröder, J; Stahl, T | 1 |
3 other study(ies) available for erucin and Cancer of Liver
| Article | Year |
|---|---|
Preclinical evaluation of 4-methylthiobutyl isothiocyanate on liver cancer and cancer stem cells with different p53 status.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Cell Movement; Cell Proliferation; Drug Resistance, Neoplasm; Humans; Immunoblotting; Isothiocyanates; Liver Neoplasms; Mice; Mice, Nude; Mutation; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
The isothiocyanate erucin abrogates telomerase in hepatocellular carcinoma cells in vitro and in an orthotopic xenograft tumour model of HCC.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; DNA Damage; Gene Expression; Hep G2 Cells; Humans; Immunoblotting; Isothiocyanates; Kidney; Liver; Liver Neoplasms; Mice, Nude; Niacinamide; Phenylurea Compounds; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sorafenib; Telomerase; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2014 |
Antigenotoxic properties of Eruca sativa (rocket plant), erucin and erysolin in human hepatoma (HepG2) cells towards benzo(a)pyrene and their mode of action.
Topics: Antimutagenic Agents; Benzo(a)pyrene; Brassicaceae; Carcinoma, Hepatocellular; Cell Line, Tumor; Chromatography, Gas; Comet Assay; Cytochrome P-450 CYP1A1; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Induction; Gene Expression Regulation, Enzymologic; Glutathione Transferase; Humans; Liver Neoplasms; Mutagens; Plant Extracts; Sulfides; Sulfones; Thiocyanates | 2008 |